By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – BG Medicine today said it has filed with US regulators for clearance of its test for predicting near-term cardiovascular events, following the successful completion of a validation study.
Registering provides access to this and other free content.
Already have an account?Login Now.
Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.
Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.
By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.
In Nature this week: a Danish reference genome, and more.